The president will also impose an additional 10% import tax on China next week and hinted at plans to soon levy 25% duties on ...

Teleflex, whose shares sank nearly 20% Thursday, will acquire most of Biotronik’s vascular intervention assets. Teleflex also ...

Tandem is following competitor Insulet’s lead with the second automated insulin delivery system indicated for Type 2 diabetes.

The pathologists group wants the regulation terminated in light of an executive order from President Trump that calls for ...

Staar’s job cuts come “amid ongoing macroeconomic and geopolitical challenges that have pressured the business,” a ...

Medtronic received Food and Drug Administration approval for the BrainSense Adaptive deep brain stimulation (DBS) device for people with Parkinson’s disease, a movement disorder of the nervous system.

Wall Street applauded the deal, sending shares of Solventum, the 3M spinoff, up 10% on Tuesday.

Perspective 6 Group is excited to announce the launch of its tailored retirement planning service for MedTech professionals.

Scott Whitaker sent a letter to the HHS calling for staff cuts at the FDA to be reversed, arguing patient care and U.S.

The cuts at the FDA’s device center could add “months, if not years” to the time it takes to bring products to market, an ...

"Any place that gets cut, it's going to have an impact, because there's not any spare personnel at FDA,” said former agency ...